Paul Herendeen

This profile gathers the share dealings of Paul Herendeen in Valeant Pharmaceuticals International, Inc. The record holds 5 filings, for trades running from 22 August 2016 to 13 March 2018.

The open-market record is one-sided, with 2 purchases worth €332k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise. In 2018 alone, the filings show 1 purchase and no sales.

The newest entry dates from 14 March 2018: an open-market purchase of €152k, in Valeant Pharmaceuticals International, Inc. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.